Table 2.
Study Visit |
BSCVA: Complete Case,N= 47 |
BSCVA: Multiple Imputation,N= 75 |
||
Mean logMAR (Snellen), 95% CI* |
PValue† |
Mean logMAR (Snellen), 95% CI* |
PValue† |
|
Enrollment | 0.85 (20/160), 0.71–0.99 | – | 0.97 (20/200), 0.85–1.09 | – |
3 wks | 0.56 (20/80), 0.44–0.68 | <0.001 | 0.63 (20/100), 0.52–0.74 | <0.001 |
3 mo | 0.43 (20/63), 0.31–0.56 | 0.002 | 0.50 (20/63), 0.38–0.62 | 0.001 |
12 mo | 0.36 (20/50), 0.25–0.47 | 0.01 | 0.45 (20/63), 0.32–0.59 | 0.31 |
4 y | 0.36 (20/50), 0.25–0.46 | 0.88 | 0.45 (20/63), 0.20–0.70 | 0.99 |
Mean logMAR BSCVA predicted from the repeated measures model, with Snellen equivalent in parentheses, followed by 95% CIs of the logMAR BSCVA.
Wald test of the hypothesis that BSCVA is the same as that of the previous study visit, as assessed from the repeated measures model.